Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The TQCC of Journal of Pharmacy and Pharmaceutical Sciences is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.95
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials72
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines70
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred29
The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy29
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs27
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments25
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition24
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer23
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs21
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome20
Pharmacological increases in circulating ketones fail to alleviate the hypertrophic cardiomyopathy present in the Tafazzin knockdown mouse model of Barth syndrome18
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System17
From fasting to fat reshaping: exploring the molecular pathways of intermittent fasting-induced adipose tissue remodeling15
Expanding the eligibility criteria for drugs in Canada’s time-limited health technology assessment and temporary drug access processes will further accelerate access to new medicines15
Effects of dual therapy with betamethasone and tetracycline in a NC/Nga mouse model of atopic dermatitis15
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy15
Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin14
Biosimilars: A Comparative Study of Regulatory, Safety and Pharmacovigilance Monograph in the Developed and Developing Economies14
Community pharmacists as antimicrobial resistance stewards: a narrative review on their contributions and challenges in low- and middle-income countries13
Exploring the Role of Sodium-Glucose Cotransporter as a New Target for Cancer Therapy12
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System12
Remdesivir-induced conduction abnormalities: A molecular model-based explanation12
Microneedles as an Alternative Strategy for Drug Delivery11
Intrahepatic cholestasis of pregnancy associated with azathioprine: first quantitative disproportionality analysis using the FDA adverse event reporting system11
Development of a submicron emulsion-based delivery system to improve the anti-inflammatory activity of urolithin A10
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective10
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis10
0.035362958908081